AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.  AdoRx’s programs are focused on the design of “fit for purpose” adenosine receptor antagonists that will overcome the effects of high adenosine levels. The Company's also doing research in the field of cancer and the immune system in order to have updated information that is used for further investigations.